BBLG

Bone Biologics
BBLG

Overview Fund Activity

5 hedge funds and large institutions have $69.7K invested in Bone Biologics in 2024 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, reducing their positions, and 2 closing their positions.

Holders
5
Holders Change
+1
Holders Change %
+25%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
UBS Group
1
UBS Group
Switzerland
$41.1K
2
HF
2
HRT Financial
New York
$21K
3
TRCT
3
Tower Research Capital (TRC)
New York
$7.06K
4
MWA
4
MFA Wealth Advisors
Pennsylvania
$492
5
Bank of America
5
Bank of America
North Carolina
$11

Top Sellers

1
AC
1
Armistice Capital
New York
$0
2
Wells Fargo
2
Wells Fargo
California
$0
Name Market Value Shares Shares
Change 		Shares
Change %
UBS Group
1
UBS Group
Switzerland
$41.1K 33,707 +33,107 +5,518%
HF
2
HRT Financial
New York
$21K 17,519 +17,519 New
TRCT
3
Tower Research Capital (TRC)
New York
$7.06K 5,789 +1,539 +36%
MWA
4
MFA Wealth Advisors
Pennsylvania
$492 403 +403 New
Bank of America
5
Bank of America
North Carolina
$11 9 +9 New
AC
6
Armistice Capital
New York
– – -37,000 Closed
Wells Fargo
7
Wells Fargo
California
– – -4 Closed
CFGS
8
Concourse Financial Group Securities
Alabama
– – – –